Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: Avoiding pitfalls in the risk calculations

American Journal of Medical Genetics

Volumn 82, Issue 4, 1999, Pages 329-335

  Hodge, Susan E ^a,b,c   Lebo, Roger V ^d   Yesley, Anne R ^d   Cheney, Susan M ^d   Angle, Heide ^e   Milunsky, Jeff ^d  

^a Columbia Sch of Phys and Surgeons ^*  (United States)

^b Columbia School of Public Health ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEWTON WELLESLEY HOSPITAL   (United States)

Author keywords

F508 mutation; Bayesian calculations; Conditional probability; Cystic fibrosis; Detectable mutations; Echogenic bowel; Risk calculations; Ultrasound findings

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; BAYES THEOREM; CASE REPORT; CYSTIC FIBROSIS; FEMALE; FETUS ECHOGRAPHY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

BAYES THEOREM; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC COUNSELING; HUMANS; INTESTINES; MUTATION; PREGNANCY; RISK ASSESSMENT; ULTRASONOGRAPHY, PRENATAL;

EID: 0033590696     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990212)82:4<329::AID-AJMG10>3.0.CO;2-D     Document Type: Article

References (15)

1. Bosco AF, Lieberman ES, Norton ME. 1997. Echogenic bowel and one cystic fibrosis mutation in the fetus: predictive of cystic fibrosis or coincidence? (abstract) J Genet Couns 6:471-472.
2. Cystic Fibrosis Genetic Analysis Consortium. 1993. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 329:1308-1313.
3. Cystic Fibrosis Genetic Analysis Consortium. 1994. Population variation of common cystic fibrosis mutations. Hum Mutat 4:167-177.
4. Cystic Fibrosis Genetic Analysis Consortium. 1998. Cystic Fibrosis Mutation Data Base. http://www.genet.sickkids.on.ca/cftr/ (June).
5. Dicke JM, Crane JP. 1992. Sonographically detected hyperechoic fetal bowel: Significance and implications for pregnancy management. Obstet Gynecol 80:778-782.
6. Hodge SE. 1998. A simple, unified approach to Bayesian risk calculations. J Genet Couns 7:235-261.
7. Irish MS, Ragi JM, Karamanoukian H, Borowitz DS, Schmidt D, Glick PL. 1997. Prenatal diagnosis of the fetus with cystic fibrosis and meconium ileus. Pediatr Surg Int 12:434-436.
8. Leporrier N, Herrou M, Herlicoviez M, Leymarie P. 1996. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18. Br J Obstet Gynaecol 103:335-338.
9. Monaghan KG, Feldman GL. 1998. The risk of cystic fibrosis in fetuses with ultrasound evidence of echogenic bowel (abstract). Am J Hum Genet 63:A169.
10. NIH Consensus Statement. 1997. Genetic testing for cystic fibrosis. Vol. 15, No. 4. National Institutes of Health, Office of the Director.
11. Peleg D, Yankowitz J. 1998. Choroid plexus cysts and aneuploidy. J Med Genet 35:554-557.
12. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J, Drumm ML, Iannuzzi MC, Collins FS, Tsui L. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245:1066-1073.
13. Sepulveda W, Leung KY, Robertson ME, Kay E, Mayall ES, Fisk NM. 1996. Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel. Obstet Gynecol 87:103-106.
14. Shin D, Gilbert F, Goldstein M, Schlegel PN. 1997. Congenital absence of the vas deferens: incomplete penetrance of cystic fibrosis gene mutations. J Urol 158:1794-1798.
15. Shrimpton AE, Borowitz D, Swender P. 1997. Cystic fibrosis mutation frequencies in upstate New York. Hum Mutat 10:436-442.